Telix Pharmaceuticals to to present at Jefferies Healthcare Conference
MELBOURNE, Australia, Jun. 03, 2019 - Telix Pharmaceuticals CEO Dr Christian Behrenbruch will present at the Jefferies Healthcare Conference
Telix Pharmaceuticals CEO Dr Christian Behrenbruch will present at the Jefferies Healthcare Conference at the Grand Hyatt Hotel in New York at 8:00 AM EDT on Tuesday, June 4. For the live audio webcast of the presentation click here.
Telix Pharmaceuticals to Acquire European Production Facility
MELBOURNE (Australia) and BRUSSELS (Belgium) – Oct. 3, 2019 - Telix Pharmaceuticals Ltd is pleased to announce that it has...
Telix Cleared to Commence Renal Cancer Imaging Study in Japan
Melbourne (Australia) and Kyoto (Japan) – 30 August 2019. Telix Pharmaceuticals Limited today announced the completion of a Clinical Trial...
FDA Pre-NDA Meeting Outcomes : TLX591-CDx (illumet™)
MELBOURNE (Australia) and INDIANAPOLIS (USA) – 28 August 2019. Telix had a pre-NDA meeting with the United States Food and...